Colorectal Cancer Treatment Resistance
Mechanisms, Insights, Advances, and Solutions
- 1st Edition - October 25, 2024
- Editor: Zodwa Dlamini
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 3 4 7 5 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 3 4 7 6 - 4
Colorectal Cancer Treatment Resistance: Mechanisms, Insights, Advances and Solutions provide insights, knowledge, and potential solutions for healthcare professionals, resear… Read more
Colorectal Cancer Treatment Resistance: Mechanisms, Insights, Advances and Solutions provide insights, knowledge, and potential solutions for healthcare professionals, researchers, and individuals affected by colorectal cancer. The book discusses innovative therapies, personalized medicine, and the latest scientific advancements in the field, all aimed at enhancing the effectiveness of treatment and improving the prognosis for colorectal cancer patients. It elucidates on the broader context of cancer research and treatment strategies that have the potential to impact the overall approach to managing colorectal cancer and, by extension, other types of cancer that may exhibit similar resistance challenges.
By studying and addressing resistance mechanisms, researchers and healthcare professionals can work towards improving patient outcomes and the overall quality of cancer care.
By studying and addressing resistance mechanisms, researchers and healthcare professionals can work towards improving patient outcomes and the overall quality of cancer care.
- Focuses on the challenges and strategies associated with overcoming treatment resistance in colorectal cancer
- Explores the various factors contributing to treatment resistance, such as genetic mutations, tumor heterogeneity, and the tumor microenvironment
- Discusses the different treatment modalities and approaches used in colorectal cancer therapy and how they can be adapted to overcome resistance
Researchers working across the biosciences in fields of oncology, virology and artificial intelligence
Part 1: Understanding Colorectal Cancer Drug Resistance
1. Unraveling the Mystery of Treatment Resistance in colorectal cancer
2. Mechanisms of Treatment Resistance in Colorectal Cancer
3. Biomarkers and Predictive Factors in Colorectal Cancer Treatment Resistance
4. Targeted Therapies and Precision Medicine in Colorectal Cancer Drug Resistance
Part 2: Innovative Approaches to Overcoming Drug Resistance
5. Overcoming Chemotherapy Resistance in Colorectal Cancer
6. Emerging Treatment Approaches for Colorectal Cancer Treatment Resistance
7. Immunotherapy and Immunomodulation in Colorectal Cancer Treatment Resistance
8. Splicing-Associated Drug Resistance in colorectal cancer: Targeting splicing signatures
9. Nanomedicine Innovations: Conquering Colorectal Cancer Drug Resistance
Part 3: Molecular Factors and Therapeutic Strategies
10. MicroRNAs in Colorectal Cancer Drug Resistance
11. Long Non-coding RNAs and Drug Resistance in Colorectal Cancer
12. Surgical Interventions and Minimally Invasive Techniques in Treatment-resistant Colorectal Cancer
13. Clinical Trials and Research Advances in Colorectal Treatment Resistance
Part 4: Future Perspectives and Advanced Research
14. Artificial Intelligence and Colorectal Cancer Drug Resistance
15. Microbiome and Colorectal Cancer Drug Resistance
16. Virally Induced Colorectal Cancer Drug Resistance
17. Future Horizons and Hope in Colorectal Cancer Drug Resistance
1. Unraveling the Mystery of Treatment Resistance in colorectal cancer
2. Mechanisms of Treatment Resistance in Colorectal Cancer
3. Biomarkers and Predictive Factors in Colorectal Cancer Treatment Resistance
4. Targeted Therapies and Precision Medicine in Colorectal Cancer Drug Resistance
Part 2: Innovative Approaches to Overcoming Drug Resistance
5. Overcoming Chemotherapy Resistance in Colorectal Cancer
6. Emerging Treatment Approaches for Colorectal Cancer Treatment Resistance
7. Immunotherapy and Immunomodulation in Colorectal Cancer Treatment Resistance
8. Splicing-Associated Drug Resistance in colorectal cancer: Targeting splicing signatures
9. Nanomedicine Innovations: Conquering Colorectal Cancer Drug Resistance
Part 3: Molecular Factors and Therapeutic Strategies
10. MicroRNAs in Colorectal Cancer Drug Resistance
11. Long Non-coding RNAs and Drug Resistance in Colorectal Cancer
12. Surgical Interventions and Minimally Invasive Techniques in Treatment-resistant Colorectal Cancer
13. Clinical Trials and Research Advances in Colorectal Treatment Resistance
Part 4: Future Perspectives and Advanced Research
14. Artificial Intelligence and Colorectal Cancer Drug Resistance
15. Microbiome and Colorectal Cancer Drug Resistance
16. Virally Induced Colorectal Cancer Drug Resistance
17. Future Horizons and Hope in Colorectal Cancer Drug Resistance
- Edition: 1
- Published: October 25, 2024
- Language: English
ZD
Zodwa Dlamini
Zodwa Dlamini is a Professor of Molecular Oncology and the founding Director and the Executive Head of the Pan African Cancer Research Institute (PACRI) in South Africa. She is the Director of South African Medical Research Council (SAMRC) Precision Oncology Research Unit (PORU). She is the DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP). She is a member of the American Association for Cancer Research (AACR) Advisory Group on Sub-Saharan Africa. She is a member of the AACR Pathology Resources in Africa Advisory Group. Professor Dlamini is a member of the African Organisation for Research and Training in Cancer (AORTIC) Research Committee Scientific Advisory Board. She is an elected member of the Academy of Science of South Africa. Professor Dlamini is an overseas Fellow of the Royal Society of Medicine (London). She is the Associate Editor for Frontiers in Oncology: Cancer Genetics Section
Affiliations and expertise
University of Pretoria, South AfricaRead Colorectal Cancer Treatment Resistance on ScienceDirect